Morgan Stanley raises Teradyne stock price target on networking growth By Investing.com

Morgan Stanley raised Teradyne’s price target to $376 from $306 while keeping an Equalweight rating, citing stronger networking test demand and upside to MarQ revenue ahead of earnings. The firm now models networking growing from 8% of the SoC test market in 2025 to 16% in 2027, but remains cautious on NVIDIA GPU testing contributions of only $200 million in fiscal 2026 and $300 million in fiscal 2027. Teradyne also continues to expand with acquisitions and product launches, including TestInsight, Photon 100, and Omnyx, while its stock trades at $384.24, above the new target.

Analysis

The setup is no longer a simple “beat-and-raise” trade; it is a debate about terminal share and mix durability. TER’s rerating has likely pulled forward a large portion of the good news, so incremental upside now depends on whether networking and system-level test become structurally larger profit pools rather than just cyclical spikes. The market will care less about headline revenue and more about whether margin expansion can persist if MarQ/Taiwan strength proves transitory or if hyperscaler capex shifts from GPU-heavy to custom ASIC-heavy test demand.

The biggest second-order winner may be the ecosystem around AI server silicon, not the obvious AI compute names. If Apple-style in-house ASIC adoption broadens, demand should migrate toward more diversified test content per socket, which benefits Teradyne’s installed base and potentially raises switching costs for smaller testers; that’s a subtle negative for niche competitors and a positive for semi-cap equipment vendors with software + hardware integration. The skeptical view on NVIDIA-related exposure also matters: if GPU test contribution stays modest, the market may be overpaying for an AI beta that is actually coming from networking, DRAM, and product test breadth.

Risk is asymmetrically to the downside over the next 1-2 earnings cycles because the stock is already pricing a lot of the forward mix improvement. If second-half demand normalizes or customer procurement gets lumpy, the multiple can compress faster than estimates move, especially with valuation already stretched. The key reversal catalyst would be any sign that networking intensity inflects slower than modeled or that MarQ strength was pulled forward by inventory timing rather than true end-demand.

Key Decisions for Investors

• Fade strength in TER via a staggered short or put spread into the next print; thesis is valuation compression if management does not validate the 2H mix ramp. Target 10-15% downside over 1-2 quarters with defined risk via call spread hedge.
• Pair trade: long AAPL / short TER for 1-3 months if the market starts pricing Apple ASIC adoption as TER-specific upside. The long captures first-party AI capex optionality while the short isolates the risk that TER has already priced in the benefit.
• Buy TER downside protection through next earnings using 1-2 month puts or put spreads; ideal if implied vol remains below realized move expectations. Risk/reward favors limited premium outlay versus a potential 15-20% drawdown on any guidance miss.
• If seeking AI equipment exposure, rotate toward names with less crowded ownership and more direct linkage to capacity expansion rather than test-mix optimism. TER is now more of a quality compounder than a clean momentum long.